#  Innovating Tinnitus Treatment

  ![](https://audiologist.org/_resources/images/zoo/4members-only.gif)### Please log in to access the recording.

 [Click here for information regarding the benefits of ADA Membership.](https://audiologist.org/membership)

**Presentation Date:** 07 September 2024

**Duration:** 1:29:04

**Return to:** [AuDacity Archive](https://audiologist.org/audacity-archive)

Tinnitus, a widespread global health issue affecting quality of life and mental well-being, now has an innovative solution: Lenire. This at-home device, the first to receive FDA approval for tinnitus treatment, employs bimodal neuromodulation to effectively reduce symptoms. Backed by a large-scale, FDA-compliant clinical trial where 83% of participants recommended it, Lenire has also shown positive outcomes in real-world settings. Over 300 patients at Alaska Hearing and Tinnitus Center experienced a strong response to a hybrid care approach using bimodal stimulation, with the vast majority responding positively at the first and second follow-up assessments.

- Attendees will be able to explain the concept of bimodal neuromodulation as it relates to tinnitus treatment.
- Attendees will be able to summarize results of clinical trials demonstrating use of bimodal neuromodulation to treat tinnitus.
- Attendees will be able to summarize real-world results with the Lenire tinnitus treatment device.

---

**Speakers:** Tish Ramirez, Au.D.; Emily McMahan, Au.D.
**Moderator:** Sam Vaught, Au.D.